期刊文献+

miRNA-200c通过抑制Akt通路提高胃癌SGC7901/DDP细胞对顺铂的敏感性 被引量:3

miRNA-200c enhances sensitivity of gastric cancer SGC7901/DDP cells to cisplatin through inhibiting Akt pathway
原文传递
导出
摘要 目的:研究miRNA-200c对人胃癌耐药SGC7901/DDP细胞顺铂敏感性的影响及其机制。方法:Western blotting检测SGC7901/DDP及其亲代SGC7901细胞E-cadherin、PTEN、p-Akt及总Akt蛋白的表达;瞬时转染miRNA-200c前体(miR-NA-200c precursor,Pre-200c)提高SGC7901/DDP细胞miRNA-200c的表达,MTT法检测转染后SGC7901/DDP细胞对顺铂的敏感性,并分析p-Akt表达的改变;应用Akt通路抑制剂LY94002处理SGC7901/DDP细胞抑制Akt磷酸化,检测处理后细胞对顺铂的敏感性。结果:与SGC7901细胞相比,SGC7901/DDP细胞中p-Akt蛋白的表达量显著增高(1.02±0.09 vs 0.17±0.02,P<0.05),E-cadherin、PTEN蛋白的表达量显著降低(0.10±0.03 vs 0.47±0.06,0.18±0.06 vs 0.87±0.06;均P<0.05)。转染Pre-200c后,顺铂对SGC7901/DDP细胞的IC50显著低于对照组[(7.52±0.19)vs(12.18±0.29)mg/L,P<0.05],细胞中p-Akt蛋白的表达量也显著低于对照组(0.22±0.04 vs 0.69±0.09,P<0.05);LY94002处理后,SGC7901/DDP细胞p-Akt蛋白的表达显著抑制(0.18±0.06 vs 0.66±0.10,P<0.05),顺铂对细胞的IC50显著低于对照组[(6.80±0.28)vs(11.94±1.73)mg/L,P<0.05]。结论:SGC7901/DDP细胞的耐药可能与E-cadherin和PTEN蛋白的表达缺失及Akt通路的异常激活有关,而miRNA-200c提高该细胞对顺铂的敏感性可能是通过抑制Akt通路而发挥作用。 Objective: To explore the effect of miRNA-200c on chemosensitivity of drug-resistant human gastric cancer SGC7901/DDP cells to cisplatin (DDP) and its mechanism. Methods: The expressions of E-cadherin, PTEN, p-Akt and total Akt proteins in SGC7901/DDP cells and its parental SGC7901 cells were detected by Western blotting, miRNA-200c precursor (Pre-200c) was transiently transfected into SGC7901/DDP cells to increase the expression of miRNA-200c. The drug sensitivity of cells to cisplatin and the expression level of p-Akt were detected by MTT assay and Western blotting, respectively. Finally, SGC7901/DDP cells were treated with LY94002 to inactivate the phosphorylation of Akt, and the sensitivity of SGC7901/DDP cells to DDP was detected. Results: Compared with SGC7901 cells, the expression of p-Akt protein in SGC7901/DDP cells was significantly increased ([ 1.02 ±0.09] vs [0.17 ±0.02], P 〈0.05), while the ex- pressions of E-cadherin and PTEN protein were significantly decreased ([0.10 ±0.03 ] vs [0.47 ± 0.06 ] ; [0.18 ± 0. 06 ] vs [ 0.87 ± 0.06 ] respectively, P 〈 0.05 ). The ICs0 of cisplatin in the Pre-200c tansfected group was significantly lower than that in the negative control group ( [ 7.52 ± 0.19 ] mg/L vs [ 12.18 ± 0.29 ] mg/L, P 〈 0.05 ). Furthermore.the expression of p-Akt protein in the Pre-200c transfected group was significantly lower than that in the control group ( [ 0.22± 0.04 ] vs [ 0.69± 0.09 ], P 〈 0.05 ) ; the level of p-Akt protein was significantly inhibited ( [ 0.18 ± 0.06 ] vs [0.66±0.10], P 〈0.05) in SGC7901/DDP cells treated with LY94002. Moreover, the ICs0 of DDP in the LY94002 treated group was significantly lower than that in the control group ( [ 6.80 ±0.28 ] mg/L vs [ 11.94 ± 1.73 ] mg/L, P 〈 0.05 ). Conclusion: Drug resistance phenotype of SGC7901/DDP cells may be associated with the loss of E-cadherin and PTEN proteins and abnormally activation of Akt signaling pathway, and the chemotherapeutic sensitization of miRNA-200c may be through the inactivation of Akt signal pathway.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2012年第6期582-587,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81172333)~~
关键词 miRNA-200c 胃癌细胞 SGC7901 耐药 磷酸化AKT AKT miRNA-200c gastric cancer cell SGC7901 drug-resistance phospho-Akt Akt
  • 相关文献

参考文献22

  • 1Calin GA, Croee CM. MicroRNA-cancer connection: The begin- ning of a new tale [J]. Cancer Res, 2006, 66 (15) : 7390-7394.
  • 2Zhang B, Pan X, Cobb GP, et al. microRNAs as oneogenes and tumor suppressors [J]. Dev Biol, 2007, 302(1) : 1-12.
  • 3Korpal M, Kang Y. The emerging role of miR-200 family of mi- croRNAs in epithelial-mesenchymal transition and cancer metasta- sis [J]. RNA Biol, 2008, 5(3) : 115-119.
  • 4Hurtean G J, Carlson JA, Spivack SD, et al. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcrip- tion factor 8 and increased expression of E-cadherin [ J ]. Cancer Res, 2007, 67 ( 17 ) : 7972-7976.
  • 5Cochrane DR, Spoelstra NS, Howe EN, et al. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targe- ting chemotherapeutic agents [ J ]. Mol Cancer Ther, 2009, 8 (5) : 1055-1066.
  • 6Adam L, Zhong M, Choi W, et al. miR-200 expression regulates cpithelial-to-mesenchymal transition in bladder cancer cells and re- verses resistance to epidermal growth factor receptor therapy [ J ]. Clin Cancer Res, 2009, 15(16) : 5060-5072.
  • 7崔秀英,郭运杰,姚和瑞.耐药乳腺癌细胞株MCF-7/ADR中microRNA的分析[J].南方医科大学学报,2008,28(10):1813-1815. 被引量:25
  • 8Li Y, VandenBoom TG 2nd, Kong D, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithe- lial-to-mesenchymal transition in gemeitabine-resistant pancreatic cancer cells[J].Cancer Res, 2009, 69(16): 670445712.
  • 9陈勇,左静,刘颖,高鸿,刘巍.miRNA-200c逆转胃癌SGC7901/DDP细胞对顺铂的耐药性及其相关机制[J].肿瘤,2010,30(8):646-650. 被引量:22
  • 10Li Z, Wang L, Zhang W, et al. Restoring E-cadherin-mediated cell-cell adhesion increases PTEN protein level and stability in hu- man breast carcinoma cells [ J ] 2007, 363(1) : 165-170.

二级参考文献71

  • 1Grishok A, Pasquinelli AE, Conte D, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing [J]. Cell, 2001, 106(1): 23-34.
  • 2Ambros V. MicroRNA pathways in flies and worms: growth, death, fat,stress ,and timing[J]. Cell, 2003, 113(6): 673-6.
  • 3Carrington JC, Ambros V. Role of microRNAs in plant and animal development[J]. Science, 2003, 301(5631): 336-8.
  • 4Calin GA, Dumitru CD, Shimizu M, et al.Frequent deletions and down-regulation ofmicro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J]. Proc Natl Acad Sci USA, 2002, 99(24): 15524-9.
  • 5Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 [J]. Proc Natl Acad Sci USA, 2005, 102(39): 13944-9.
  • 6Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis [J].Cancer Cell, 2006, 9(3): 189-98.
  • 7Kovalchuk O, Tryndyak YP, Montgomery B, et al. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression[J]. Cell Cycle, 2007, 6(16): 2010-8.
  • 8Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis [ J ]. Nature, 2008, 451(7175): 147-52.
  • 9Yu F, Yao H, Zhu P, et al. let-7 regulates self-renewal and tumorigenesis of breast cancer cells [J]. Cell, 2007, 131 (6): 1109-23.
  • 10Mishra PJ, Humeniuk R, Mishra PJ, et al. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance [J]. Proe Natl Acad Sci USA, 2007, 104 (33): 13513-8.

共引文献56

同被引文献29

  • 1胡梅洁,曾晖,章永平,张曙,乔敏敏,付华,吴云林.苦参碱联合5-氟尿嘧啶对人胃癌裸鼠移植瘤的抑制作用[J].中华消化杂志,2005,25(4):219-221. 被引量:28
  • 2Park Sun-Mi,Gaur Arti B,Lengyel Ernst,Peter Marcus E.The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes and Development . 2008
  • 3Cochrane Dawn R,Spoelstra Nicole S,Howe Erin N,Nordeen Steven K,Richer Jennifer K.MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Molecular Cancer . 2009
  • 4Yong Chen,Ying Sun,Longbang Chen,Xingxiang Xu,Xizhi Zhang,Buhai Wang,Lingfeng Min,Wei Liu.miRNA-200c increases the sensitivity of breast cancer cells to doxorubicinthrough the suppression of E-cadherin-mediated PTEN/Akt signaling[J]. Molecular Medicine Reports . 2013 (5)
  • 5Miao Zhong,Xin Ma,Caijun Sun,Ling Chen.MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer[J]. Chemico-Biological Interactions . 2010 (3)
  • 6Leskel? Susanna,Leandro-García Luis J,Mendiola Marta,Barriuso Jorge,Inglada-Pérez Lucía,Mu?oz Iván,Martínez-Delgado Beatriz,Redondo Andrés,de Santiago Javier,Robledo Mercedes,Hardisson David,Rodríguez-Antona Cristina.The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocrine Related Cancer . 2010
  • 7Sarah Jurmeister,Marek Baumann,Aleksandra Balwierz.MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F. Molecular and Cellular Probes . 2012
  • 8J. L. Bryant,J. Britson,J. M. Balko.A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT. British Journal of Cancer . 2012
  • 9Mok T,Yang J J,Lam K C.Treating patients with EGFRsensitizing mutations:first line or second line——is there a difference?. Journal of Clinical Oncology . 2013
  • 10Van Schaeybroeck Sandra,Kyula Joan,Kelly Donal M,Karaiskou-McCaul Anthi,Stokesberry Susan A,Van Cutsem Eric,Longley Daniel B,Johnston Patrick G.Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells. Molecular Cancer . 2006

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部